Attys Get $2.5M In $7.5M Preterm-Birth Drug Settlement
A New Jersey federal judge has given final approval to a $7.5 million settlement to end claims that AMAG Pharmaceuticals Inc. knew its preterm-birth prevention drug Makena was ineffective when it...To view the full article, register now.
Already a subscriber? Click here to view full article